In these dark days when people already suffering from impeded breathing are threatened by Covid-19, such reports as this offer a glimmer of hope. However, as Asthma UK point out, the Irish research is at a very early stage "and done in animals. There will need to be further studies but there is a lot of potential here though if they could show a therapeutic effect of targeting the human form in clinical trials." Asthma UK (now merged with the British Lung Foundation) has itself been funding research into proteins triggering allergic reactions causing inflammation.
No comments:
Post a Comment